Lion Point Capital, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Lion Point Capital, Lp disclosed 30 stock positions valued at approximately $20.91M as of quarter-end June 30, 2026. The largest holdings include PRAXIS PRECISION MEDICINES I, MOONLAKE IMMUNOTHERAPEUTICS, and FENNEC PHARMACEUTICALS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 30
- Portfolio Value
- $20.91M
Holdings by Sector
Lion Point Capital, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 7.13% | 4,450 | - | - | $1,489,816 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 6.29% | 67,500 | - | - | $1,314,225 |
| FENNEC PHARMACEUTICALS INC | FENC | Healthcare | 5.78% | 112,434 | - | - | $1,208,666 |
| ROYALTY PHARMA PLC | RPRX | Other | 5.74% | 21,400 | - | - | $1,199,898 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 5.41% | 80,000 | - | - | $1,132,000 |
| MILESTONE PHARMACEUTICALS IN | MIST | Healthcare | 5.26% | 820,000 | - | - | $1,098,800 |
| BENITEC BIOPHARMA INC | BNTC | Healthcare | 3.97% | 62,000 | - | - | $829,560 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 3.76% | 36,000 | - | - | $786,960 |
| GERON CORP | GERN | Healthcare | 3.54% | 578,000 | - | - | $739,840 |
| UNIQURE NV | QURE | Other | 3.24% | 14,700 | - | - | $677,082 |
| ARDELYX INC | ARDX | Healthcare | 3.14% | 128,650 | - | - | $656,115 |
| LANTHEUS HLDGS INC | LNTH | Healthcare | 2.92% | 5,500 | - | - | $610,170 |
| DISC MEDICINE INC | IRON | Healthcare | 2.83% | 8,100 | - | - | $592,434 |
| SAREPTA THERAPEUTICS INC | SRPT | Healthcare | 2.45% | 28,500 | - | - | $512,145 |
| HUMACYTE INC | HUMA | Healthcare | 2.43% | 650,000 | - | - | $507,260 |
| KURA ONCOLOGY INC | KURA | Healthcare | 2.41% | 46,000 | - | - | $504,620 |
| VIATRIS INC | VTRS | Healthcare | 2.10% | 27,700 | - | - | $439,876 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.91% | 18,000 | - | - | $399,780 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 1.78% | 5,000 | - | - | $372,400 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 1.77% | 9,100 | - | - | $369,733 |
| PACIRA BIOSCIENCES INC | PCRX | Healthcare | 1.64% | 13,500 | - | - | $342,495 |
| REGENXBIO INC | RGNX | Healthcare | 1.52% | 26,600 | - | - | $318,668 |
| ROCKET PHARMACEUTICALS INC | RCKT | Healthcare | 1.41% | 86,000 | - | - | $294,120 |
| JANUX THERAPEUTICS INC | JANX | Healthcare | 1.40% | 19,000 | - | - | $291,840 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.36% | 10,500 | - | - | $283,290 |
| GH RESEARCH PLC | GHRS | Other | 1.31% | 10,200 | - | - | $274,176 |
| AZENTA INC | AZTA | Healthcare | 1.18% | 9,700 | - | - | $247,544 |
| JASPER THERAPEUTICS INC | JSPR | Healthcare | 0.94% | 465,000 | - | - | $195,765 |
| INNOVIVA INC | INVA | Healthcare | 0.89% | 8,200 | - | - | $186,222 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 0.66% | 5,250 | - | - | $137,655 |
Showing 30 of 30 holdings in the latest reporting period.